ABBOTT LABORATORIES — Director's Dealing 2007

Feb 21, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-15

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-15	Common shares without par value	F	78900	$52.70	Disposed	843073	Direct
2007-02-16	Common shares without par value	A	140000	$52.54	Acquired	983073	Direct
2007-02-17	Common shares without par value	F	18279	$52.49	Disposed	964794	Direct
2007-02-18	Common shares without par value	F	8390	$52.49	Disposed	956404	Direct
2007-02-20	Common shares without par value	F	21698	$52.49	Disposed	934706	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-16	Option (right to buy)	$52.54	A	550000	Acquired	2017-02-15	common shares (550000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17106	Indirect
Common shares without par value	4755	Indirect
Common shares without par value	4755	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2007.

F3: The reporting person disclaims beneficial ownership of all securities held by sons.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 183,334 on 2/16/08, 183,333 on 2/16/09 and 183,333 on 2/16/10.